Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Florida Cancer Specialists & Research Institute, Orlando, Florida Sarah Cannon Research Institute (SCRI), Nashville, Tennessee Oncology Consultants, Houston, Texas China
Henan Cancer Hospital, Zhengzhou, Henan Union Hospital of Tongji Medical College, Wuhan, Hubei Sir Run Run Shaw Hospital, Hangzhou, Zhejiang Shanghai East Hospital, Shanghai